Enterovirus 71 meningoencephalitis complicating rituximab therapy

被引:17
作者
Ahmed, Rebekah [1 ]
Buckland, Michael [2 ]
Davies, Leo [1 ]
Halmagyi, G. Michael [1 ]
Rogers, Shannon L. [3 ]
Oberste, Steven [3 ]
Barnett, Michael H. [1 ]
机构
[1] Univ Sydney, Royal Prince Alfred Hosp, Inst Clin Neurosci, Sydney, NSW 2006, Australia
[2] Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia
[3] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
Enterovirus; 71; Encephalitis; Rituximab; Monoclonal antibody; ANTI-CD20; MONOCLONAL-ANTIBODY; DIRECT IDENTIFICATION; AMPLIFICATION; SEROTYPES; LYMPHOMA;
D O I
10.1016/j.jns.2011.03.009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We describe a fatal case of proven enterovirus 71 meningoencephalitis complicating monoclonal anti-CD20 antibody therapy for non-Hodgkin's lymphoma. B-cell depletion, an effective treatment strategy in an expanding spectrum of hematological and inflammatory disorders, impairs neutralising antibody-mediated clearance of enterovirus. The global threat of emerging neurotropic viruses such as enterovirus 71 is heightened by an increasing pool of susceptible individuals in non-endemic regions. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:149 / 151
页数:3
相关论文
共 12 条
[1]   Opportunistic enteroviral meningoencephalitis: an unusual treatable complication of rituximab therapy [J].
Ganjoo, Kristen N. ;
Raman, Raghav ;
Sobel, Raymond A. ;
Pinto, Harlan A. .
LEUKEMIA & LYMPHOMA, 2009, 50 (04) :673-675
[2]   Neurologic complications in children with enterovirus 71 infection [J].
Huang, CC ;
Liu, CC ;
Chang, YC ;
Chen, CY ;
Wang, ST ;
Yeh, TF .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (13) :936-942
[3]   Direct identification of human enterovirus serotypes in cerebrospinal fluid by amplification and sequencing of the VP1 region [J].
Leitch, E. C. McWilliam ;
Harvala, H. ;
Robertson, I. ;
Ubillos, I. ;
Templeton, K. ;
Simmonds, R. .
JOURNAL OF CLINICAL VIROLOGY, 2009, 44 (02) :119-124
[4]   Rituximab chimeric Anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:: Half of patients respond to a four-dose treatment program [J].
McLaughlin, P ;
Grillo-López, AJ ;
Link, BK ;
Levy, R ;
Czuczman, MS ;
Williams, ME ;
Heyman, MR ;
Bence-Bruckler, I ;
White, CA ;
Cabanillas, F ;
Jain, V ;
Ho, AD ;
Lister, J ;
Wey, K ;
Shen, D ;
Dallaire, BK .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2825-2833
[5]   An overview of the evolution of enterovirus 71 and its clinical and public health significance [J].
McMinn, PC .
FEMS MICROBIOLOGY REVIEWS, 2002, 26 (01) :91-107
[6]   Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens [J].
Nix, W. Allan ;
Oberste, M. Steven ;
Pallansch, Mark A. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (08) :2698-2704
[7]  
Oberste AS, 2005, REV MED MICROBIOL, V16, P163
[8]   Enteroviral meningoencephalitis in a patient with non-Hodgkin's lymphoma treated previously with rituximab [J].
Padate, BP ;
Keidan, J .
CLINICAL AND LABORATORY HAEMATOLOGY, 2006, 28 (01) :69-71
[9]   Outbreak of neurologic enterovirus type 71 disease:: A diagnostic challenge [J].
Perez-Velez, Carlos M. ;
Anderson, Marsha S. ;
Robinson, Christine C. ;
McFarland, Elizabeth J. ;
Nix, W. Allan ;
Pallansch, Mark A. ;
Oberste, M. Steven ;
Glode, Mary P. .
CLINICAL INFECTIOUS DISEASES, 2007, 45 (08) :950-957
[10]   Rituximab, an anti-CD20 monoclonal antibody: History and mechanism of action [J].
Pescovitz, MD .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (05) :859-866